| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 26.54× | 26.54× | 25.27× | 21.64× | 19.83× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −1.90× | −1.89× | −2.43× | −2.06× | −1.95× | ||
| 0.62× | 0.62× | 0.63× | 0.59× | 0.57× | ||
| −1.95× | −1.95× | −150.41× | 92.30× | −1.72× | ||
| 3.06× | 3.06× | 1.79× | 1.30× | 0.69× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 19.83 | 21.64 | 25.27 | 26.54 | 26.54 | |
| Working Capital Turnover | -1.95 | -2.06 | -2.43 | -1.89 | -1.90 | |
| Asset Turnover | 0.57 | 0.59 | 0.63 | 0.62 | 0.62 | |
| Cash Conversion (CFO/Net Income) | -1.72 | 92.30 | -150.41 | -1.95 | -1.95 | |
| CFO/EBITDA | 0.69 | 1.30 | 1.79 | 3.06 | 3.06 |